BIOX logo

BIOCERES CROP SOLUTIONS CORP

BIOXNASDAQ
πŸ† #4126 by market capUS Equity
$0.37β–² $0.01 (+3.00%)
Live
1hβ–² 0.6%
24hβ–² 3.0%
7dβ–Ό 0.6%
14dβ–² 16.0%
30dβ–² 9.0%
1yβ–Ό 88.3%
🏦Market Cap
$24M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-44.7%
Declining
πŸ“ŠGross Margin
37.6%
Healthy
πŸ’΅FCF Margin
28.4%
Strong
βš–οΈP/S Ratio
0.1x
Cheap
Otter Score
50
Weak

Trading Snapshot

Day Range
$0.37 – $0.38
52-Week Range
$0.30 – $3.33
Volume
$2.57B
Avg Volume
$3.38B
Shares Outstanding
63.8M
Next Earnings
Sep 6, 2026

Fundamentals Snapshot

Annual Revenue
$265M
Last Q Revenue
$64M
P/E Ratio
β€”
P/S Ratio
0.1x
EPS (TTM)
$-3.88
Dividend Yield
β€”

Why Investors Own BIOX

  • βœ“High-growth profile β€” revenue up +47.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 39% gross margin and 22% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$265Mβ–² +54.3% YoY
Gross Margin (TTM)
39.0%β–² +1.0% YoY
Operating Income (TTM)
$50Mβ–² +54.3% YoY
Free Cash Flow (TTM)
$58Mβ–² +54.3% YoY

About BIOCERES CROP SOLUTIONS CORP

A company profile for BIOCERES CROP SOLUTIONS CORP isn’t available yet β€” check back soon.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
50/100

Analyst Price Target

β“˜
Average Target
$0.44
β–² +17.6% Upside
High Target$0.51
Low Target$0.34
Based on 20 analysts

Latest News & Updates